Patent law

Crello Breaks the Rules of Photobanks for Creators

Retrieved on: 
Monday, May 17, 2021
Expense, Intellectual property law, Patent law, Royalty payment

b'LIMASSOL, Cyprus, May 17, 2021 /PRNewswire/ --Crello, an online graphic designplatform, is launching Crello Unlimited , an expansive royalty-free library with no limits on attribution or downloads.

Key Points: 
  • b'LIMASSOL, Cyprus, May 17, 2021 /PRNewswire/ --Crello, an online graphic designplatform, is launching Crello Unlimited , an expansive royalty-free library with no limits on attribution or downloads.
  • In addition to being able to download these assets, they can be used anywhere.
  • Usually, creators have a choice between free stocks with overused images or paid photo banks with limits on assets usage or additional fee per asset.
  • But Crello Pro users will now have the entire Unlimited library at their disposal.\nThere is also a Crello Starter plan, which is free.

Monopar Therapeutics Reports First Quarter 2021 Financial Results and Recent Business Updates

Retrieved on: 
Thursday, May 13, 2021
Patent law, Communication, Forward-looking statement, United States patent law, Articles, Term of patent in the United States, Patent, Term of patent

This patent expires in 2038, not including any patent term extensions.

Key Points: 
  • This patent expires in 2038, not including any patent term extensions.
  • Actual results may differ materially from those expressed or implied by such forward-looking statements.
  • All forward-looking statements contained in this press release speak only as of the date on which they were made.
  • Monopar undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made.

Freehold Royalties Ltd. Announces First Quarter 2021 Results and Increases Dividend by 33%

Retrieved on: 
Tuesday, May 11, 2021
Expense, Intellectual property law, Patent law, Royalty payment

Drilling activity on our lands over the quarter was in-line with expectations, with our core royalty positions in the Viking, Cardium and Sparky, continuing to attract capital.

Key Points: 
  • Drilling activity on our lands over the quarter was in-line with expectations, with our core royalty positions in the Viking, Cardium and Sparky, continuing to attract capital.
  • In the U.S. there has been strong activity on our royalty lands in both the Permian and Eagle Ford basins.
  • Total consideration associated with these transactions was approximately $4.9 million with the assets estimated to add 85 boe/d to 2021 average production.
  • Overall, 18 gross wells were drilled on our U.S. royalty lands over the quarter with between 4-5 rigs continuing to drill on our lands.

Kaplan Fox & Kilsheimer LLP and Pomerantz LLP Announce a Notice of Pendency of Class Action and Proposed Settlement in Lewis v. YRC Worldwide Inc.

Retrieved on: 
Monday, May 10, 2021
Patent claim, Patent law, Settlement

If you have not yet received the Notice and Claim Form, you may get copies of them by contacting the Claims Administrator at YRC Securities Litigation, c/o A.B.

Key Points: 
  • If you have not yet received the Notice and Claim Form, you may get copies of them by contacting the Claims Administrator at YRC Securities Litigation, c/o A.B.
  • Box 173127, Milwaukee, WI 53217; (877) 265-3022; or [email protected] .
  • If you properly exclude yourself from the Class, you will not be bound by any judgments or orders entered by the Court in the Action, and you will not be eligible to receive a payment from the Settlement.
  • All questions about this notice, the proposed Settlement, or your eligibility to participate in the Settlement should be directed to the Claims Administrator or Lead Counsel.\nRequests for the Notice and Claim Form should be made to:\n'

Dicerna Announces First Quarter 2021 Financial Results and Provides a Business Update

Retrieved on: 
Thursday, May 6, 2021
General Health, Health, Science, Other Science, Research, Expense, Intellectual property law, Patent law, Royalty payment

With the additional influx of $180 million in non-dilutive cash from the monetization of our lumasiran royalty, we hope to meet our goal of net-zero cash burn in 2021.

Key Points: 
  • With the additional influx of $180 million in non-dilutive cash from the monetization of our lumasiran royalty, we hope to meet our goal of net-zero cash burn in 2021.
  • In March 2021, Dicerna announced that Roche initiated RG6346 in a Roche-sponsored Phase 2 combination trial for the treatment of chronic HBV.
  • ET today to review Dicerna\'s first quarter 2021 financial results and provide a general business update.
  • The call will also be webcast and will be available under the \xe2\x80\x9cInvestors & Media\xe2\x80\x9d section of the Dicerna website, www.dicerna.com .

Cannabics Pharmaceuticals Receives Patent "Notice of Allowance" From The Mexican Patent and Trademark Office (IMPI)

Retrieved on: 
Thursday, May 6, 2021
Intellectual property law, European Patent Organisation, Patent law, European Patent Office, Patent application, Patent, Outline of patents, Patent prosecution

The decision of the Mexican patent authority follows the European Patent Office (EPO) "Intention to Grant a European Patent"notice to the company from October 2020, concerning the same patent application.\nEyal Barad, Cannabics Pharmaceuticals\' co-founder and CEO commented: "This patent application is a great example of Cannabics\'s innovative and novel approach to the drug discovery process in our field.

Key Points: 
  • The decision of the Mexican patent authority follows the European Patent Office (EPO) "Intention to Grant a European Patent"notice to the company from October 2020, concerning the same patent application.\nEyal Barad, Cannabics Pharmaceuticals\' co-founder and CEO commented: "This patent application is a great example of Cannabics\'s innovative and novel approach to the drug discovery process in our field.
  • The patent was already granted in Israel and in South Africa, and we have been notified of intention to grant in Europe and now also in Mexico.
  • This opens many interesting opportunities for the company in these markets, which we intend to develop and grow.
  • We undertake no duty to update any forward-looking statement or any information contained in this press release or other public disclosures at any time.

New Music NFT Platform BAND Royalty Just Sold 3 NFTS for $200K

Retrieved on: 
Wednesday, May 5, 2021
Expense, Intellectual property law, Patent law, Royalty payment, Royalty, NFT, Blockchain art, Musical groups, Non-fungible token

BAND NFTs, which are one of a kind digital collectibles in a growing and crowded NFT marketplace, actually have something solid behind them - a sought after catalog of top music royalties.

Key Points: 
  • BAND NFTs, which are one of a kind digital collectibles in a growing and crowded NFT marketplace, actually have something solid behind them - a sought after catalog of top music royalties.
  • BAND Royalty, for the first time in the world, offers music lovers and fans the opportunity to access a piece of their favorite artists songs as a royalty stream.
  • Funds generated will be reinvested to expand BAND Royalty\xe2\x80\x99s music royalty library.\nSecuring one of the converted and rare 3,000 Series 1 collectible BAND NFT 3D animated music inspired pieces of digital art is simple.
  • To learn more about BAND Royalty and to sign up for NFT collection release drops, visit www.bandroyalty.com .\n'

QuickFreeze® Patents Issued and New Patents Pending for Vacant Positions, Height Compensation, Side Seals, Spacers

Retrieved on: 
Tuesday, May 4, 2021
Patent law, Monopoly, Patent, Pallet

Patent # 10,807,764 issued in October and #10,863,759 issued in December 2020.

Key Points: 
  • Patent # 10,807,764 issued in October and #10,863,759 issued in December 2020.
  • There are also multiple applications pending.\nVacant Positions - Until now, full occupancy for In-Rack freezing systems has been critical to proper performance.
  • This patent and other patents-pending provides operators with an excellent remedy to the Vacant Position problem.
  • QuickFreeze innovations include the patented QF+ In-Rack Freezing System, the T2 Spacer, and recently QFM, "The fastest way to freeze a pallet."

Palatin Announces U.S. Patent Term Extension for Vyleesi® (bremelanotide injection)

Retrieved on: 
Tuesday, May 4, 2021
Intellectual property law, Patent law, Term of patent in the United States, United States patent law, Intellectual property organizations, Term of patent, International Searching and Preliminary Examining Authorities, Patent offices, Bremelanotide, Drug Price Competition and Patent Term Restoration Act, United States Patent and Trademark Office, Patent

For more information on Vyleesi, go to www.vyleesi.com .\nThe patent term extension is pursuant to the Drug Price Competition and Patent Term Restoration Act of 1984, commonly called the Hatch-Waxman Amendments, which permits an extension of the term of one patent for a maximum period of five years as compensation for patent term lost during drug development and the FDA regulatory review process.

Key Points: 
  • For more information on Vyleesi, go to www.vyleesi.com .\nThe patent term extension is pursuant to the Drug Price Competition and Patent Term Restoration Act of 1984, commonly called the Hatch-Waxman Amendments, which permits an extension of the term of one patent for a maximum period of five years as compensation for patent term lost during drug development and the FDA regulatory review process.
  • An interim extension for a period of one year from the original expiration date of both patents of June 25, 2020, was granted by the USPTO in May 2020.
  • In the Notices of Final Determination issued by the USPTO, the maximum allowable five-year extension was granted.\nPalatin has filed an Election to extend the patent term of U.S. patent 6,794,489.
  • Palatin is not responsible for updating for events that occur after the date of this press release.\nView original content to download multimedia: http://www.prnewswire.com/news-releases/palatin-announces-us-patent-term...\n'

Custodian REIT plc : Unaudited net asset value as at 31 March 2021 and dividend update

Retrieved on: 
Tuesday, May 4, 2021
Finance, Money, Economy, Monopoly, Patent law, Patent portfolio, Investment, Portfolio, Dividend

The Board\'s objective is to grow the dividend on a sustainable basis, at a rate which is fully covered by projected net rental income and does not inhibit the flexibility of the Company\'s investment strategy.\n6 This is a target only and not a profit forecast.

Key Points: 
  • The Board\'s objective is to grow the dividend on a sustainable basis, at a rate which is fully covered by projected net rental income and does not inhibit the flexibility of the Company\'s investment strategy.\n6 This is a target only and not a profit forecast.
  • There can be no assurance that the target can or will be met and it should not be taken as an indication of the Company\'s expected or actual future results.
  • During the previous quarter the Company charged five unencumbered properties valued at \xc2\xa321.1m to add additional headroom to certain facilities.\nAt 31 March 2021 the Company\'s property portfolio comprised 159 assets with a net initial yield7 of 6.6% (31 December 2020: 6.7%).
  • The portfolio is split between the main commercial property sectors, in line with the Company\'s objective to maintain a suitably balanced investment portfolio.